By a GenomeWeb staff reporter
The funding will be used primarily to set up a European multi-center clinical trial for the validation of a molecular test to predict non-response to anti-TNF treatment, in particular Remicade.
Celera names Merriweather as SVP and CFO; TcLand Expression appoints Payne as CBO.
The French firm also said it has received $564,000 in funding for the project.
Patrick Terry, Lisa Wise, James O'Leary
Jack Lord is named president and CEO of Navigenics, while Celera has a new CFO, and Patrick Terry joins the board of directors of TcLand Expression, plus more.
With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.
NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.
CNBC reports that there are thousands of genetic tests available for consumers to chose between.
In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.